1-12 of 12
Jennifer A. Woyach
Close
Sort by
Journal Articles

Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials

Clinical Trials & Observations
Matthew S. Davids, Jeff P. Sharman, Paolo Ghia, Jennifer A. Woyach, Toby A. Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo Miranda, Mina Shahkarami, Anna Butturini, Ugochinyere Emeribe, John C. Byrd
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3345–3359.
https://doi.org/10.1182/bloodadvances.2023011307
Published: 2024
Includes: Supplemental data
Journal Articles

A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia

Clinical Trials & Observations
Paul J. Hampel, Mahesh Swaminathan, Kerry A. Rogers, Erin M. Parry, Jan A. Burger, Matthew S. Davids, Wei Ding, Alessandra Ferrajoli, Jonathan M. Hyak, Nitin Jain, Saad S. Kenderian, Yucai Wang, William G. Wierda, Jennifer A. Woyach, Sameer A. Parikh, Philip A. Thompson
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2342–2350.
https://doi.org/10.1182/bloodadvances.2023012080
Published: 2024
Includes: Supplemental data
Journal Articles

Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization

Samantha M. Teierle, Ying Huang, Adam S. Kittai, Seema A. Bhat, Michael Grever, Kerry A. Rogers, Weiqiang Zhao, Daniel Jones, John C. Byrd, Matthew R. Avenarius, Nyla A. Heerema, Jennifer A. Woyach, Cecelia R. Miller
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7239–7242.
https://doi.org/10.1182/bloodadvances.2023010753
Published: 2023
Includes: Supplemental data
Journal Articles

Racial and socioeconomic disparities in CLL/SLL: analysis of SEER data from 2006 to 2019

Adam S. Kittai, Ying Huang, Seema A. Bhat, Electra D. Paskett, Kerry A. Rogers, Jacqueline C. Barrientos, James L. Fisher, Jennifer A. Woyach
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2575–2579.
https://doi.org/10.1182/bloodadvances.2022008643
Published: 2023
Journal Articles

Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy

Max Yano, Chia Sharpe, J. Rachel Lance, Janani Ravikrishnan, Kevan Zapolnik, Xiaokui Mo, Jennifer A. Woyach, Deepa Sampath, Adam S. Kittai, Sumithira Vasu, Seema Bhat, Kerry A. Rogers, Dean A. Lee, Natarajan Muthusamy, John C. Byrd
Journal: Blood Advances
Blood Adv (2022) 6 (20): 5641–5654.
https://doi.org/10.1182/bloodadvances.2021005883
Published: 2022
Includes: Supplemental data
Journal Articles

Differential regulation of CTLA4 expression through BTK-dependent and independent mechanisms in CLL

Max Yano, Jessica Nunes, Xiaokui Mo, Kerry A. Rogers, Jennifer A. Woyach, John C. Byrd, Natarajan Muthusamy
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5440–5448.
https://doi.org/10.1182/bloodadvances.2021005571
Published: 2022
Journal Articles

Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes

Clinical Trials & Observations
Jonathan M. Hyak, Ying Huang, Kerry A. Rogers, Seema A. Bhat, Michael R. Grever, John C. Byrd, Adam S. Kittai, Dan Jones, Cecelia R. Miller, Jennifer A. Woyach
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5124–5127.
https://doi.org/10.1182/bloodadvances.2022007708
Published: 2022
Includes: Supplemental data
Journal Articles

Safety of venetoclax rapid dose escalation in CLL patients previously treated with B-cell receptor signaling antagonists

Clinical Trials & Observations
Kristin L. Koenig, Ying Huang, Emily K. Dotson, Shane Sheredy, Seema A. Bhat, John C. Byrd, Emily Desmond, Jill Ford, Shauna Iarocci, Jeffrey A. Jones, Margaret S. Lucas, Mollie E. Moran, Tracy E. Wiczer, Jennifer A. Woyach, Farrukh T. Awan, Kerry A. Rogers
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4860–4863.
https://doi.org/10.1182/bloodadvances.2020002593
Published: 2020
Includes: Supplemental data
Journal Articles

Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome

Clinical Trials & Observations
Adam S. Kittai, David A. Bond, Basem William, Ayman Saad, Sam Penza, Yvonne Efebera, Karilyn Larkin, Sarah A. Wall, Hannah K. Choe, Bhavana Bhatnagar, Sumithira Vasu, Jonathan Brammer, Polina Shindiapina, Meixiao Long, Alice Mims, Lynn O’Donnell, Seema A. Bhat, Kerry A. Rogers, Jennifer A. Woyach, John C. Byrd, Samantha M. Jaglowski
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4648–4652.
https://doi.org/10.1182/bloodadvances.2020002783
Published: 2020
Journal Articles

Resistance mechanism for ibrutinib in marginal zone lymphoma

Clinical Trials & Observations
Narendranath Epperla, Arwa Y. Shana’ah, Dan Jones, Beth A. Christian, Sabarish Ayyappan, Kami Maddocks, Jennifer A. Woyach
Journal: Blood Advances
Blood Adv (2019) 3 (4): 500–502.
https://doi.org/10.1182/bloodadvances.2018029058
Published: 2019
Includes: Supplemental data
Journal Articles

Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib

Clinical Trials & Observations
Cecelia R. Miller, Amy S. Ruppert, Nyla A. Heerema, Kami J. Maddocks, Jadwiga Labanowska, Heather Breidenbach, Gerard Lozanski, Weiqiang Zhao, Amber L. Gordon, Jeffrey A. Jones, Joseph M. Flynn, Samantha M. Jaglowski, Leslie A. Andritsos, Kristie A. Blum, Farrukh T. Awan, Kerry A. Rogers, Michael R. Grever, Amy J. Johnson, Lynne V. Abruzzo, Erin K. Hertlein, James S. Blachly, Jennifer A. Woyach, John C. Byrd
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1584–1588.
https://doi.org/10.1182/bloodadvances.2017007302
Published: 2017
Includes: Supplemental data
Journal Articles

Novel SF3B1 in-frame deletions result in aberrant RNA splicing in CLL patients

Clinical Trials & Observations
Anant A. Agrawal, Michael Seiler, Lindsey T. Brinton, Rose Mantel, Rosa Lapalombella, Jennifer A. Woyach, Amy J. Johnson, Ping Zhu, Markus Warmuth, Lihua Yu, John C. Byrd, Peter G. Smith, James S. Blachly, Silvia Buonamici
Journal: Blood Advances
Blood Adv (2017) 1 (15): 995–1000.
https://doi.org/10.1182/bloodadvances.2017007062
Published: 2017
Includes: Supplemental data